|
HALO® is the most technologically advanced assay platform available for multiple lymph-hematopoietic stem and progenitor cell populations. It replaces the CFU assay by being:
- Instrument-based
- Non-subjective
- Standardized and validated
- Incorporates SEC™ Technology and, therefore, methylcellulose-free
- Allows high-throughput capability in 96- or 384-well plates
- Has built-in proficiency testing
- More rapid (results in 6 days or less), reliable and reproducible than any CFU assay
- Available for multiple species and different applications
- Used by biopharmaceutical companies worldwide
To learn more about HALO® and our other instrument-based hematopoietic assays, please visit our website or contact us directly by calling 719-264-6251 or e-mailing info@preferred-cell-systems.com.
|